Psychiatric markers - interleukins treatment - cytokine alterations

1. Myint AM, Schwarz MJ, Steinbusch HWM, Leonard BE. Neuropsychiatric Disorders related to Interferon and Interleukins treatment. Metabolic Brain Diseases 2008. DOI: 10.1007/s11011-008-9114-5. Epub 2008 Dec.
2. Kim YK, Myint AM, Verkerk R, Scharpe S, Steinbusch H, Leonard BE. Cytokine changes and tryptophan metabolites in medication-naïve and medication-free Schizophrenic patients. Neuropsychobiology 2008 (accepted).
3. Myint AM, Kim YK, Verkerk R, Park SH, Scharpé S, Steinbusch HW, Leonard BE. Tryptophan breakdown pathway in bipolar mania. J Affect Disord. 2007 Sep; 102(1-3):65-72. Epub 2007 Jan 30.
4. Myint AM, Kim YK, Verkerk R, Scharpé S, Steinbusch H, Leonard B. Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord. 2007 Feb; 98(1-2):143-51. Epub 2006 Sep 6.
5. Myint AM, Schawaller M, Verkerk R, Schwarz MJ, Hampel H, Müller N. Neurodegenerative markers for psychiatric conditions, Patent application at: Fa. Diamed Eurogen, Belgium: October 12, 2006: Patent publication No: WO2006105907.
6. Myint AM, Leonard BE, Steinbusch HW, Kim YK. Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord. 2005 Oct; 88(2):167-73.
7. Kim YK, Myint AM, Lee BH, Han CS, Lee HJ, Kim DJ, Leonard BE. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Nov; 28(7):1129-34.
8. Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses. 2003 Nov-Dec; 61(5-6):519-25.
9. Oades RD, Dauvermann MR, Schimmelmann BG, Schwarz MJ, Myint AM. Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism - effects of medication. Behavioral and Brain Functions 2010; 6:29.
10. Oades RD, Myint AM, Dauvermann MR, Schimmelmann BG, Schwarz MJ. Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention. Behavioral and Brain Functions 2010; 6:32.
11. Majoie HJM, Rijkers K, Berfelo MW, Hulsman JARJ, Myint A, Schwarz M, Vles JSH. Vagus Nerve Stimulation in Refractory Epilepsy: Effects on Pro- and Anti-Inflammatory Cytokines in Peripheral Blood. Neuroimmunomodulation 2011 July; 18:52-56.
12. Claes S, Myint AM, Domschke K, Del-Favero J, Entrich K, Engelborghs S, De Deyn P, Mueller N, Baune B, Rothermundt M. The kynurenine pathway in major depression: Haplotype analysis of three related functional candidate genes. Psych. Res. 2011
13. Myint AM, Schwarz MJ, Verkerk R, Mueller HH, Zach J, Scharpé S, Steinbusch HWM, Leonard BE, Kim YK. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients. Brain, Behavior, and Immunity 2011.
14. Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, Sarnyai Z, Mawrin C, Brisch R, Bielau H, Meyer zu Schwabedissen L, Bogerts B, Myint AM. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission. Journal of Neuroinflammation 2011; 8:94
15. Myint AM and Schwarz MJ (2011). Interaction Between Inflammatory State and Neurochemical Changes in Major Psychiatric Disorders, Psychiatric Disorders - Worldwide Advances, Toru Uehara (Ed.), ISBN: 978-953-307-833-5, InTech, Available from: http://www.intechopen.com/articles/show/title/interaction-between-inflammatory-state-and-neurochemical-changes-in-major-psychiatric-disorders

Do you have a question? Feel free to contact us.